Nigella sativa seeds and Febrile Neutropenia

Effect of Nigella sativa seed administration on prevention of Febrile Neutropenia during chemotherapy among children with Brain Tumors attending the Pediatric oncology unit in Alexandria Main University Hospital.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201503001039326

Enrollment

Registered

2015-02-18

Start date

2014-02-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer brain tumors

Interventions

effect of nigella sativa seed administration on prevention of febrile neutropenia

effect of nigella sativa seed administration on prevention of Febrile Neutropenia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: children (2-18)years with primary brain tumors.

Exclusion criteria

Exclusion criteria: 1. children with any type of cancer other than brain tumors. 2. children with relapsed brain tumors.

Design outcomes

Primary

Measure	Time frame
prevention of febrile neutropenia during chemotherapy cycles;number of admissions to hospital as a result of febrile neutropenia.;Length of hospital stay upon admission as a result of Febrile Neutropenia.	—

Secondary

Measure	Time frame
improvement of chemotherapy-related haematological and GIT toxicities	—

Countries

Egypt

Contacts

Public ContactHebatullah Moussa

drheba_fmoussa@yahoo.com00201115144443

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026